Healthpeak Properties (NYSE:DOC) Sets New 52-Week High – Still a Buy?

Healthpeak Properties, Inc. (NYSE:DOCGet Free Report) shares reached a new 52-week high on Tuesday . The stock traded as high as $21.91 and last traded at $21.8950, with a volume of 6078294 shares traded. The stock had previously closed at $21.55.

Wall Street Analyst Weigh In

DOC has been the topic of several analyst reports. Morgan Stanley reiterated an “equal weight” rating and set a $22.00 price target (up from $20.00) on shares of Healthpeak Properties in a report on Thursday, June 11th. JPMorgan Chase & Co. upped their price objective on shares of Healthpeak Properties from $18.00 to $21.00 and gave the stock a “neutral” rating in a report on Wednesday, June 24th. UBS Group raised their target price on shares of Healthpeak Properties from $17.00 to $19.00 and gave the company a “neutral” rating in a research note on Wednesday, May 13th. Citigroup lifted their target price on shares of Healthpeak Properties from $17.50 to $20.00 and gave the stock a “neutral” rating in a report on Tuesday, May 12th. Finally, Wall Street Zen upgraded shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a report on Sunday, May 10th. Three research analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $19.93.

Read Our Latest Stock Analysis on Healthpeak Properties

Healthpeak Properties Trading Up 1.2%

The company has a current ratio of 2.96, a quick ratio of 2.96 and a debt-to-equity ratio of 1.15. The stock has a market capitalization of $14.94 billion, a P/E ratio of 67.71, a P/E/G ratio of 3.34 and a beta of 1.02. The business’s fifty day simple moving average is $19.33 and its two-hundred day simple moving average is $17.78.

Healthpeak Properties (NYSE:DOCGet Free Report) last posted its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.02. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The company had revenue of $752.95 million for the quarter, compared to the consensus estimate of $694.59 million. During the same quarter in the previous year, the firm posted $0.46 EPS. The business’s revenue was up 7.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, analysts forecast that Healthpeak Properties, Inc. will post 1.75 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The company also recently disclosed a monthly dividend, which was paid on Friday, June 26th. Shareholders of record on Monday, June 15th were given a $0.1017 dividend. The ex-dividend date was Monday, June 15th. This represents a c) dividend on an annualized basis and a dividend yield of 5.6%. Healthpeak Properties’s dividend payout ratio (DPR) is currently 381.25%.

Insider Buying and Selling at Healthpeak Properties

In other news, insider Scott R. Bohn sold 10,989 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the sale, the insider directly owned 7,636 shares in the company, valued at approximately $148,520.20. The trade was a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.23% of the company’s stock.

Institutional Investors Weigh In On Healthpeak Properties

A number of institutional investors have recently bought and sold shares of DOC. WPG Advisers LLC raised its stake in shares of Healthpeak Properties by 270.2% in the 4th quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock valued at $26,000 after buying an additional 1,197 shares in the last quarter. Advocate Investing Services LLC bought a new stake in Healthpeak Properties in the fourth quarter valued at about $26,000. Elyxium Wealth LLC acquired a new position in Healthpeak Properties in the fourth quarter worth about $31,000. Clearstead Advisors LLC raised its position in Healthpeak Properties by 166.3% in the fourth quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock worth $31,000 after purchasing an additional 1,216 shares in the last quarter. Finally, CYBER HORNET ETFs LLC acquired a new position in Healthpeak Properties in the second quarter worth about $33,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

About Healthpeak Properties

(Get Free Report)

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

Read More

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.